Get the Stockscreener App
6.14
0.10%
-0.010
Teladoc Health Inc stock is traded at $6.14, with a volume of 1.74M.
It is down -0.10% in the last 24 hours and down -1.23% over the past month.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
See More
Previous Close:
$6.13
Open:
$6.19
24h Volume:
1.74M
Relative Volume:
0.40
Market Cap:
$1.11B
Revenue:
$2.51B
Net Income/Loss:
$-171.15M
P/E Ratio:
-6.3739
EPS:
-0.9633
Net Cash Flow:
$122.59M
1W Performance:
-2.49%
1M Performance:
-1.23%
6M Performance:
+12.98%
1Y Performance:
-27.10%
1-Day Range:
$6.07
$6.235
1-Week Range:
$6.07
$6.47
52-Week Range:
$4.40
$9.8868
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, BTSG, TXG, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.13 | 1.11B | 2.51B | -171.15M | 122.59M | -0.9633 |
VEEV
Veeva Systems Inc
|
275.37 | 43.84B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
81.63 | 13.91B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.21 | 11.04B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
84.75 | 9.85B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
92.00 | 7.45B | 646.34M | -512.40M | 202.76M | -6.6871 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-26-26 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Teladoc Health stock falls 3.46 percent after weak Q2 revenue - AD HOC NEWS
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Teladoc Health stock holds near USD 6.26 as revenue pressure persists - AD HOC NEWS
Teladoc Health CEO Charles Divita sells $108,681 in shares By Investing.com - Investing.com South Africa
Teladoc Health CEO Charles Divita sells $108,681 in shares - Investing.com
Form 4 Teladoc Inc For: 23 September By Investing.com - Investing.com India
The Bull Case For Teladoc Health (TDOC) Could Change Following Weak Q2 Results And Lowered Guidance - Yahoo Finance
Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Teladoc Health (TDOC) Slips 2.20% to $6.43, Drifting Toward Key SupportInstitutional Volume - careplusvn.com
Stock awards vest for Teladoc (NYSE: TDOC) CEO as he sells shares to cover taxes - stocktitan.net
Teladoc Share PriceTDOC, RNS News, Articles, Quotes, & Charts (NYSE:TDOC) - Proactive financial news
Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life - Seeking Alpha
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - moomoo.com
Why Teladoc (TDOC) Outpaced the Stock Market Today - Yahoo Finance
Teladoc Health (TDOC) executive plans 17.8K-share stock sale - stocktitan.net
Avoiding Lag: Real-Time Signals in (TDOC) Movement - Stock Traders Daily
2 Beaten-Down Stocks to Avoid Right Now - The Globe and Mail
Here's Why Teladoc's Integrated Care Business Deserves More Attention - The Globe and Mail
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Bliss Kelly - Moomoo
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
Teladoc Health (TDOC) CEO sells 18,327 shares after stock awards vest - Stock Titan
Equity awards vest for Teladoc Health (NYSE: TDOC) accounting chief - Stock Titan
15,311 stock units vest for Teladoc (TDOC) exec as she sells shares for taxes - stocktitan.net
Teladoc Health (TDOC) exec sells shares to cover taxes after 14,928 units vest - stocktitan.net
RSU vesting prompts Teladoc (TDOC) executive to sell shares for taxes - Stock Titan
Teladoc Health (NYSE: TDOC) president sells 15,251 shares - Stock Titan
Teladoc Health (NYSE: TDOC) officer plans sale of 9,812 recently vested shares - stocktitan.net
The Escalator: GSK, Teladoc, FINN Partners and more - Medical Marketing and Media
Planned stock sale by Teladoc (NYSE: TDOC) officer covers 7,357 shares - Stock Titan
Teladoc Health (NYSE: TDOC) insider lines up 5,439-share stock sale tied to vested awards - Stock Titan
Teladoc (NYSE: TDOC) exec plans stock sale, including shares to cover taxes on vested stock - Stock Titan
Teladoc (NYSE: TDOC) officer plans $39K stock sale - Stock Titan
Teladoc Health (NYSE: TDOC) holder plans 18,327-share Rule 144 sale - Stock Titan
Teladoc Health (NYSE: TDOC) Names Grasher Michael F as CFO and Records New Insider Status - Kalkine Media
Teladoc Health stock rises on a new CFO and steady July results - AD HOC NEWS
Here's Why Investors Should Stay Neutral on TDOC Stock for Now - TradingView
Teladoc Health CFO Michael F. Grasher Granted 239,616 Restricted Stock Units on September 1, 2026 - Kalkine Media
Teladoc Health Appoints Michael Grasher as New CFO - theglobeandmail.com
Insider at Teladoc (TDOC) reports new stock trades - Stock Titan
Teladoc (NYSE: TDOC) CFO Michael Grasher listed as insider with no trades reported - Stock Titan
What Teladoc Health (TDOC)'s New Insurance-Focused CFO Appointment Means For Shareholders - simplywall.st
CCORF Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10 - moomoo.com
Teladoc nabs insurance veteran as new CFO - Healthcare Dive
Teladoc appoints insurance executive Michael Grasher as CFO - Y100 WNCY
Some People Are Leaning On AI For Mental Health Support. Here's Why It’s Not a Substitute For A Licensed Therapist - forbes.com
Teladoc Health names Michael Grasher as chief financial officer By Investing.com - Investing.com South Africa
Teladoc Health names Michael Grasher as chief financial officer - Investing.com
Teladoc Health Appoints Michael Grasher as Chief Financial Officer - globenewswire.com
Teladoc (TDOC) Down 3.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc.TDOC - PR Newswire
BetterHelp Has the Demand: Can Teladoc Build the Capacity? - Yahoo Finance
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):